(Q30767882)

English

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials (English)

1 reference

Europe PubMed Central

26 June 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Perucca

1

1 reference

Europe PubMed Central

26 June 2017

B E Gidal

2

1 reference

Europe PubMed Central

26 June 2017

Eugène Baltès

3

1 reference

Europe PubMed Central

26 June 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

26 June 2017

Epilepsy Research

1 reference

Europe PubMed Central

26 June 2017

53

1 reference

Europe PubMed Central

26 June 2017

1-2

1 reference

Europe PubMed Central

26 June 2017

47-56

1 reference

Europe PubMed Central

26 June 2017

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology and therapeutic use of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dose increments on serum carbamazepine concentration in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of levetiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-1211(02)00250-4

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30767882&oldid=1647824399"